Because the Oncotype DX test is performed on a small portion of the tissue removed during the original surgery (needle biopsy, breast lumpectomy, or mastectomy), you do not need to undergo surgeries or additional procedures to get tested.
Since it became available in 2004, nearly 750,000 Oncotype breast cancer screenings have been requested in more than 90 countries. The Oncotype DX test was studied and approved in 14 independent studies involving more than 4,000 patients with invasive breast cancer.
The Oncotype DX test has been carried out in Latin America since 2006 and its use is booming. The test can be paid by yourself or your health insurance, if you have one. You are advised to always contact the insurer first.
* Surgeon or oncologist